Proa Medical has been granted patents for its first single-use device, Brella Vaginal Retractor, in China and Russia.
The company was granted a US patent for its device from the United States Patent and Trademark Office on 9 June 2015.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
In approximately half of all deliveries, repair of vaginal and perineal lacerations secondary to childbirth is said to be among the most frequently performed surgical procedures worldwide.
The Brella Vaginal Retractor is used in hospitals’ labour and delivery departments for hands-free retraction and deep illumination.
Featuring a canopy design incorporating a bright, deep light source, the Brella Vaginal Retractor device is used to provide optimal visualisation and access during vaginal or perineal wound repair.
The built-in light source is designed to provide a clear and unobstructed view of the vaginal walls and surrounding structures.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataProa Medical Chief Executive Officer and a registered US patent attorney Arman Nadershahi said: "We are very pleased with the issuance of this patent in China and Russia for Proa Medical.
"In addition to providing intellectual property protection in large markets, the issuance of these patents confirms the Chinese State Intellectual Property Office’s and Russian Federal Service for Intellectual Property’s recognition that the Brella represents a new and innovative medical device."
Currently, the company is also pursuing patent protection for its device portfolio in several other countries.
